Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Dreussi E, Pucciarelli S, De Paoli A, Polesel J, Canzonieri V, Agostini M, Friso ML, Belluco C, Buonadonna A, Lonardi S, Zanusso C, De Mattia E, Toffoli G, Cecchin E. Dreussi E, et al. Among authors: friso ml. Oncotarget. 2016 Apr 12;7(15):19781-93. doi: 10.18632/oncotarget.7757. Oncotarget. 2016. PMID: 26934318 Free PMC article.
Rectal cancer neoadjuvant treatment in elderly patients.
Pasetto LM, Friso ML, Pucciarelli S, Basso U, Falci C, Bortolami A, Toppan P, Agostini M, Rugge M, Serpentini S, Nitti D, Monfardini S. Pasetto LM, et al. Among authors: friso ml. Anticancer Res. 2006 Sep-Oct;26(5B):3913-23. Anticancer Res. 2006. PMID: 17094422 Free article.
Rectal cancer adjuvant chemotherapy: when is more useful?
Pasetto LM, Basso U, Sinigaglia G, Pucciarelli S, Friso ML, Rugge M, Toppan P, Agostini M, Monfardini S. Pasetto LM, et al. Among authors: friso ml. Anticancer Res. 2008 May-Jun;28(3B):1805-12. Anticancer Res. 2008. PMID: 18630464 Free article.
Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Pucciarelli S, Rampazzo E, Briarava M, Maretto I, Agostini M, Digito M, Keppel S, Friso ML, Lonardi S, De Paoli A, Mescoli C, Nitti D, De Rossi A. Pucciarelli S, et al. Among authors: friso ml. Ann Surg Oncol. 2012 Sep;19(9):3089-96. doi: 10.1245/s10434-012-2272-z. Epub 2012 Mar 7. Ann Surg Oncol. 2012. PMID: 22395986
Role of neoadjuvant treatment in cT3N0M0 rectal cancer.
Pasetto LM, Friso ML, Pucciarelli S, Basso U, Rugge M, Sinigaglia G, Rossi E, Compostella A, Toppan P, Agostini M, Monfardini S. Pasetto LM, et al. Among authors: friso ml. Anticancer Res. 2008 Nov-Dec;28(6B):4129-35. Anticancer Res. 2008. PMID: 19192672 Free article.
Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study.
De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, Del Prete S, Pasetto L, Santantonio M, Sarti E, Mantello G, Innocente R, Frustaci S, Corvò R, Rosso R. De Paoli A, et al. Among authors: friso ml. Ann Oncol. 2006 Feb;17(2):246-51. doi: 10.1093/annonc/mdj041. Epub 2005 Nov 9. Ann Oncol. 2006. PMID: 16282246 Free article. Clinical Trial.
34 results